Land: Australien
Språk: engelska
Källa: Department of Health (Therapeutic Goods Administration)
potassium clavulanate, Quantity: 151.917 mg; amoxicillin trihydrate, Quantity: 573.892 mg
Micro Labs Pty Ltd
amoxicillin trihydrate,potassium clavulanate
Tablet, film coated
Excipient Ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; dichloromethane; isopropyl alcohol; sodium starch glycollate; titanium dioxide; hypromellose; propylene glycol; purified talc; ethylcellulose
Oral
Alu/Alu strip packs of 10 tablets packed in monocarton
(S4) Prescription Only Medicine
AMCLAVOX DUO 500/125 tablets are indicated for short-term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to Microbiology):,Urinary Tract Infections (complicated and uncomplicated),Lower Respiratory Tract Infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis,Upper Respiratory Tract Infections, such as sinusitis, otitis media and recurrent tonsillitis.,Skin and Skin Structure Infection.,Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxicillin and clavulanic acid tablets. However, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to amoxicillin and clavulanic acid tablets preparations should not require the addition of another antibiotic due to the amoxicillin content of these products.
Visual Identification: White colored capsule shaped film coated tablet debossed with 'I 06' on one side and plain on other side.; Container Type: Strip Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2017-08-07
AMCLAVOX DUO 500/125 & AMCLAVOX DUO FORTE 875/125 TABLETS Amoxicillin and clavulanic acid CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? Please read this leaflet carefully before you take AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets. This leaflet answers some common questions about AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Sometimes new risks are found even when a medicine has been used for many years. Your doctor has weighed the expected benefits of you taking AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets against the risks this medicine could have for you. If you have any concerns about taking this medicine, ask your doctor or pharmacist. Keep this leaflet with the medicine. You may need to read it again. WHAT ARE AMCLAVOX DUO & AMCLAVOX DUO FORTE TABLETS USED FOR? AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets contain two active ingredients. One of these is a penicillin called amoxicillin and the other is clavulanic acid. AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets belong to the penicillin group of antibiotics. AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets are used for the short term treatment of a wide range of infections caused by bacteria. These infections may affect the chest (e.g. bronchitis or pneumonia), bladder (e.g. cystitis), sinuses (e.g. sinusitis), the ears (e.g. otitis media) or the skin. AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets work by killing the bacteria that cause these infections. AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets will not work against infections caused by viruses such as colds or the flu. Your doctor may prescribe AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets for another use. If you want more information, ask your doctor. There is no evidence that AMCLAVOX DUO & AMCLAVOX DUO FORTE tablets are addictive. BEFORE YOU TAKE AMCLAVOX DUO & AMCLAVOX DUO FORTE TABLETS _Do not take AMCLAVOX _ _DUO & AMCLAVOX _ _DUO FORTE tablets if: _ • You hav Läs hela dokumentet
AMCLAVOX DUO TABLETS 1 AUSTRALIAN PRODUCT INFORMATION- AMCLAVOX DUO FORTE 875/125 AND AMCLAVOX DUO 500/125 (AMOXICILLIN AND CLAVULANIC ACID) FILM-COATED TABLETS 1. NAME OF THE MEDICINE Amoxicillin (as trihydrate) and clavulanic acid (as potassium). 2. QUALITATIVE AND QUANTITATIVE COMPOSITION AMCLAVOX DUO tablets are combination products containing the semisynthetic antibiotic, amoxicillin (as the trihydrate) and the β-lactamase inhibitor, potassium clavulanate (as the potassium salt of clavulanic acid). AMCLAVOX DUO FORTE 875/125 & AMCLAVOX DUO 500/125 tablets also contain the inactive ingredients: Microcrystalline cellulose, magnesium stearate, sodium starch glycollate Type A and colloidal anhydrous silica. The tablet coating contains hypromellose, titanium dioxide, propylene glycol, purified talc, ethylcellulose. 3. PHARMACEUTICAL FORM AMCLAVOX DUO 500 /125 tablets contain amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium clavulanate) 125 mg. White colored capsule shaped film coated tablet debossed with ‘Ɩ 06’ on one side and plain on other side. AMCLAVOX DUO FORTE 875 /125 tablets contain amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium clavulanate) 125 mg. White colored capsule shaped film coated tablet debossed with ‘Ɩ 07’ on one side and plain on other side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS AMCLAVOX DUO tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to Microbiology): Urinary Tract Infections (uncomplicated and complicated) Lower Respiratory Tract Infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis Upper Respiratory Tract Infections, such as sinusitis, otitis media and recurrent tonsillitis. Skin and Skin Structure Infection Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxicillin and clavulanic acid tablet Läs hela dokumentet